Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction

NCT07303985 is registered in ClinicalTrials.gov with Jun Zhang as lead sponsor.

NCT NCT07303985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction
Lead sponsor
Jun Zhang
Phase
Phase 3
Overall status
Completed
Start date
December 29, 2025
Completion date
March 1, 2026
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral blood flow